Lasker Foundation President Claire Pomeroy argues that the development of cost-effective therapies and cures for disease flounders when Congress short-changes medical research funding.
Lasker Foundation President Claire Pomeroy argues that the development of cost-effective therapies and cures for disease flounders when Congress short-changes medical research funding.
